Patents Assigned to CREATE Medicines, Inc.
  • Methods and compositions for genomic integration
    Patent number: 12599678
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Grant
    Filed: May 5, 2023
    Date of Patent: April 14, 2026
    Assignee: CREATE Medicines, Inc.
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly